WallStreetZenWallStreetZen

NYSE: GSK
Gsk PLC Stock Forecast, Predictions & Price Target

Analyst price target for GSK

Based on 3 analysts offering 12 month price targets for Gsk PLC.
Min Forecast
$44.00+7.03%
Avg Forecast
$46.33+12.7%
Max Forecast
$48.00+16.76%

Should I buy or sell GSK stock?

Based on 3 analysts offering ratings for Gsk PLC.
Buy
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GSK stock forecasts and price targets.

GSK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-30
lockedlocked$00.00+00.00%2024-01-23
lockedlocked$00.00+00.00%2024-01-03

1 of 1

Forecast return on equity

Is GSK forecast to generate an efficient return?
Company
139.88%
Industry
136.71%
Market
79%
GSK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GSK forecast to generate an efficient return on assets?
Company
33.09%
Industry
25.16%
GSK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GSK earnings per share forecast

What is GSK's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$4.11+45.08%
Avg 2 year Forecast
$4.53+59.72%
Avg 3 year Forecast
$5.06+78.61%
GSK's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GSK revenue forecast

What is GSK's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$39.7B+0.82%
Avg 2 year Forecast
$42.3B+7.28%
Avg 3 year Forecast
$44.9B+13.85%
GSK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GSK earnings growth forecast

How is GSK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
22.64%
Industry
46.76%
Market
18.61%
GSK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GSK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GSK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GSK revenue growth forecast

How is GSK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
5.74%
Industry
9.05%
Market
9.85%
GSK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GSK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GSK vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
GSK$41.11$46.33+12.70%Buy
BMY$42.41$51.40+21.20%Hold
GILD$64.34$80.91+25.75%Buy
SNY$48.44$55.00+13.54%Hold
BIIB$230.63$280.95+21.82%Buy

Gsk Stock Forecast FAQ

Is Gsk Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: GSK) stock is to Buy GSK stock.

Out of 3 analysts, 1 (33.33%) are recommending GSK as a Strong Buy, 0 (0%) are recommending GSK as a Buy, 2 (66.67%) are recommending GSK as a Hold, 0 (0%) are recommending GSK as a Sell, and 0 (0%) are recommending GSK as a Strong Sell.

If you're new to stock investing, here's how to buy Gsk stock.

What is GSK's earnings growth forecast for 2024-2026?

(NYSE: GSK) Gsk's forecast annual earnings growth rate of 22.64% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 46.76%, and while it is forecast to beat the US market's average forecast earnings growth rate of 18.61%.

Gsk's earnings in 2024 is $5,535,802,469.On average, 6 Wall Street analysts forecast GSK's earnings for 2024 to be $16,620,840,000, with the lowest GSK earnings forecast at $16,297,320,000, and the highest GSK earnings forecast at $17,146,560,000. On average, 6 Wall Street analysts forecast GSK's earnings for 2025 to be $18,299,100,000, with the lowest GSK earnings forecast at $17,672,280,000, and the highest GSK earnings forecast at $19,087,680,000.

In 2026, GSK is forecast to generate $20,462,640,000 in earnings, with the lowest earnings forecast at $18,804,600,000 and the highest earnings forecast at $21,675,840,000.

What is GSK's revenue growth forecast for 2024-2026?

(NYSE: GSK) Gsk's forecast annual revenue growth rate of 5.74% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Gsk's revenue in 2024 is $37,950,617,283.On average, 4 Wall Street analysts forecast GSK's revenue for 2024 to be $160,682,666,268,000, with the lowest GSK revenue forecast at $159,991,194,840,000, and the highest GSK revenue forecast at $161,672,609,160,000. On average, 4 Wall Street analysts forecast GSK's revenue for 2025 to be $170,976,830,028,000, with the lowest GSK revenue forecast at $167,292,313,320,000, and the highest GSK revenue forecast at $174,457,715,160,000.

In 2026, GSK is forecast to generate $181,451,497,728,000 in revenue, with the lowest revenue forecast at $173,306,550,120,000 and the highest revenue forecast at $186,730,284,600,000.

What is GSK's forecast return on assets (ROA) for 2024-2027?

(NYSE: GSK) forecast ROA is 33.09%, which is higher than the forecast US Drug Manufacturers - General industry average of 25.16%.

What is GSK's Price Target?

According to 3 Wall Street analysts that have issued a 1 year GSK price target, the average GSK price target is $46.33, with the highest GSK stock price forecast at $48.00 and the lowest GSK stock price forecast at $44.00.

On average, Wall Street analysts predict that Gsk's share price could reach $46.33 by May 30, 2025. The average Gsk stock price prediction forecasts a potential upside of 12.7% from the current GSK share price of $41.11.

What is GSK's Earnings Per Share (EPS) forecast for 2024-2026?

(NYSE: GSK) Gsk's current Earnings Per Share (EPS) is $2.73. On average, analysts forecast that GSK's EPS will be $4.11 for 2024, with the lowest EPS forecast at $4.03, and the highest EPS forecast at $4.24. On average, analysts forecast that GSK's EPS will be $4.53 for 2025, with the lowest EPS forecast at $4.37, and the highest EPS forecast at $4.72. In 2026, GSK's EPS is forecast to hit $5.06 (min: $4.65, max: $5.36).

What is GSK's forecast return on equity (ROE) for 2024-2027?

(NYSE: GSK) forecast ROE is 139.88%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.